For example, when co-cultured with sorafenib-resistant HCC cells, CAFs can be activated through the B-cell activating factor (BAFF) / NF-κB pathway to further enhance the chemoresistance of HCC [49]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.